InsidersTradesSigma
Follow the Transcode Therapeutics, Inc. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, Transcode Therapeutics, Inc. has recorded 10 public disclosures. Market capitalisation: €8m. The latest transaction was reported on 5 August 2026 (C). Among the most active insiders: Dudley Robert Michael. The full history is openly available.
10
Insider Decl.
n/a
Thresholds
€269,443
8 ops.
Buy Volume
n/a
n/a
Sell Volume
58Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 August 2026
Declarations10 total
98,000 shares@ US$0.5120.5% of flowCommon StockSEC:0001104659-23-105924:0
Canonical exit: 27 Dec 2023 (T+90)
49,350 shares@ US$0.5162.3% of flowCommon StockSEC:0001104659-23-105925:0
Canonical exit: 27 Dec 2023 (T+90)
6,607 shares@ US$2.54986.7% of flowCommon StockSEC:0001104659-23-073872:0
Canonical exit: 18 Sept 2023 (T+90)
19,000 shares@ US$2.7621.0% of flowCommon StockSEC:0001104659-23-071204:0
Canonical exit: 7 Sept 2023 (T+90)
19,000 shares@ US$2.7621.0% of flowCommon StockSEC:0001104659-23-070804:0
Canonical exit: 7 Sept 2023 (T+90)
20,000 shares@ US$1.1510.0% of flowCommon StockSEC:0001104659-22-100931:0
Canonical exit: 13 Dec 2022 (T+90)
12,000 shares@ US$1.270.24% mcap100.0% of flowCommon StockSEC:0001104659-22-072369:0
Canonical exit: 14 Sept 2022 (T+90)
28,000 shares@ US$1.84440.80% mcap100.0% of flowCommon StockSEC:0001104659-22-067099:0
Canonical exit: 25 Aug 2022 (T+90)
10 of 10 declarations
About Transcode Therapeutics, Inc.
Transcode Therapeutics, Inc. is a company focused on developing innovative therapies for cancer treatment. It specializes in RNA-based solutions to enhance patient outcomes.